Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_022081.6(HPS4):c.751A>T(p.Thr251Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00924 in 1,613,952 control chromosomes in the GnomAD database, including 92 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
HPS4 (HGNC:15844): (HPS4 biogenesis of lysosomal organelles complex 3 subunit 2) This gene encodes a protein component of biogenesis of lysosome-related organelles complexes (BLOC). BLOC complexes are important for the formation of endosomal-lysosomal organelles such as melanosomes and platelet dense granules. Mutations in this gene result in subtype 4 of Hermansky-Pudlak syndrome, a form of albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
Computational evidence support a benign effect (MetaRNN=0.0051202774).
BP6
Variant 22-26465507-T-A is Benign according to our data. Variant chr22-26465507-T-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 341016.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=3, Uncertain_significance=2}. Variant chr22-26465507-T-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00694 (1057/152208) while in subpopulation AMR AF= 0.0124 (189/15298). AF 95% confidence interval is 0.0109. There are 9 homozygotes in gnomad4. There are 468 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
May 29, 2019
Johns Hopkins Genomics, Johns Hopkins University
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Oculocutaneous albinism Uncertain:1
Dec 21, 2016
Genetics - Synnovis, NHS South East Genomic Laboratory Hub
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
This variant may be associated with cardiomyopthy. There 3 individuals present in the ExAC database that are homozygous for this variant. Insufficient evidence to move out of uncertain significance classification. -
Hermansky-Pudlak syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not specified Benign:1
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
Thr251Ser in exon 10 of HPS4: This variant is not expected to have clinical sign ificance because it has been identified in 1.1% (94/8600) of European American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs34962745). -
not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter